FDA approval expands EBGLYSS maintenance dosing to once every eight weeks, offering fewer injections for patients with ...

The trial aims to enrol approximately 50 MASH patients.

"Once-monthly dosing could offer a more manageable alternative to today's more frequent injections," Buse noted in a ...

Apogee Therapeutics advances zumilokibart with a $1.3B Blackstone deal, eyes $82.97 value despite asset risks. Read why APGE ...

Early trial data support quarterly dosing of an under-the-skin Briumvi formulation now being tested in Phase 3 for relapsing ...

Chemotherapy is a vital treatment for people with all forms of cancer. It's a process that uses drugs designed to kill, damage or slow the spread of cancer cells, preventing them from growing and ...

The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as ...

If you're the parent of a baby or a young child, you’ve probably woken up in the middle of the night to find your child crying out in pain or sweating from a fever. This situation can be scary if you ...

Fully enrolled, randomized, double-blind, sham-controlled Phase 2 study has completed treatment administration in 99 patients ...